Stockscreener 앱 받기
0.1138
5.25%
-0.0063
시장 영업 전:
.12
0.0062
+5.45%
전일 마감가:
$0.1201
열려 있는:
$0.12
하루 거래량:
1.59M
Relative Volume:
0.19
시가총액:
$5.11M
수익:
-
순이익/손실:
$-11.00M
주가수익비율:
-0.2877
EPS:
-0.3956
순현금흐름:
$-11.99M
1주 성능:
-14.05%
1개월 성능:
-36.78%
6개월 성능:
-85.48%
1년 성능:
-99.06%
1일 변동 폭
$0.1107
$0.125
1주일 범위
$0.1107
$0.1489
52주 변동 폭
$0.1107
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
명칭
Liminatus Pharma Inc
전화
213-273-5453
주소
12611 HIDDENCREEK WAY, CERRITOS
Compare LIMN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.1138 | 5.39M | 0 | -11.00M | -11.99M | -0.3956 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
Liminatus Pharma (LIMN) Faces Selling Pressure, Testing Key Support at $0.11Money Flow - newsline.com
Liminatus Pharma Warrants (LIMNW) Holds at $0.08 as Trading StallsPut Flow Alert - newsline.com
Liminatus Pharma (LIMN) Extends Decline, Testing Key Support at $0.11OBV Breakout - newsline.com
LIMN Should I Buy - Intellectia AI
Liminatus Pharma Warrants (LIMNW) Hold Steady Near Key Support LevelVolume Oscillator - newsline.com
Liminatus Pharma (LIMN) Slips 5.77% as Selling Pressure Persists Below $0.14 ResistanceJelly Roll Trade - newsline.com
Liminatus Pharma Inc. (LIMN) Slides 5.95% as Stock Tests Key Support at $0.13Regression Channel - newsline.com
Liminatus Pharma secures $1.9M cash via warrant exercises - MSN
Liminatus Pharma Secures Liquidity Through Warrant Inducement Deal - TipRanks
[8-K] Liminatus Pharma, Inc. Reports Material Event - Stock Titan
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds - The Manila Times
Liminatus Pharma (NASDAQ: LIMN) cuts warrant exercise price; 13.8M warrants tied to 20.7M shares - Stock Titan
Liminatus Pharma (LIMN) Slides 8.89%: Testing Key $0.15 Support LevelVolatility Stop - newsline.com
Liminatus Pharma (LIMN) Slips 6% as Stock Tests Key Support at $0.16Order Block - newsline.com
LIMINATUS PHARMA, INC. Files Form 8-K for NASDAQ Listing – Company Information and SEC Filing Details - Minichart
Liminatus Pharma (LIMN) Holds Steady Near Resistance – Consolidation Phase May Precede Directional MoveSentiment Extreme - newsline.com
Liminatus Pharma Appeals Nasdaq Delisting, Listing Temporarily Intact - TipRanks
Liminatus Pharma Received Notice of Delisting - TradingView
Liminatus Pharma (LIMN) appeals Nasdaq delisting after market value shortfall - Stock Titan
Liminatus Pharma Inc. (LIMN) Surges Over 12% as Bullish Momentum BuildsBPI Reversal - The Legal Advocate
Liminatus Pharma - The Pharma Letter
Liminatus Pharma (LIMN) Shares Slide 3.25% as Selling Pressure Mounts Near SupportRetail Volume - newsline.com
Liminatus Pharma(LIMN) Stock Options Chain | Quotes & News - Moomoo
Liminatus announces proposed merger with InnocsAI - The Pharma Letter
Liminatus Pharma notifies NASDAQ of impending delisting; plans to appeal - MSN
Liminatus Pharma is trending overnight — here's why LIMN stock surged over 79% in after-hours session - MSN
Liminatus Pharma (LIMN) Faces Delisting from Nasdaq - GuruFocus
Liminatus Pharma (LIMN) Faces Nasdaq Delisting Notice Amid Compl - GuruFocus
Liminatus Pharma (LIMN) Plunges 31% as Support Level Approaches – Key Levels to WatchExpert Breakout Alerts - Newser
Liminatus Pharma receives Nasdaq delisting notice - TipRanks
Number of shareholders of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
LIMN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Unusual volume stocks in Friday's session - ChartMill
Liminatus Pharma (LIMN) Stock: Surges Ahead of Nasdaq Delisting Deadline - MEXC
Liminatus Pharma (LIMN) Stock: Nasdaq Delisting Warning Sparks Volatile Trading Session - Blockonomi
Liminatus Pharma (LIMN) Stock Jumps 31% Despite Looming Nasdaq Delisting Threat - MoneyCheck
Liminatus Pharma faces Nasdaq delisting after compliance failure - Investing.com India
Liminatus Pharma faces Nasdaq delisting after compliance failure By Investing.com - Investing.com Australia
Liminatus Pharma to be delisted from Nasdaq for failing market value rules, plans to appeal. - Pluang
Liminatus Pharma Announces Nasdaq Delisting Notification - lincolnjournal.com
Liminatus Pharma, Inc. Receives Nasdaq Delisting Notice Following Non-Compliance With Market Value Requirements - Moomoo
Liminatus Pharma, Inc. Receives Nasdaq Delisting Notice Following Non-Compliance with Market Value Requirements - Quiver Quantitative
Liminatus Pharma faces Nasdaq delisting after market value shortfall - Stock Titan
Liminatus Pharma Inc (LIMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.27%
1.43%
자본화:
|
볼륨(24시간):